CoChat

Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects

Open access
Yang, Song, Han, Gaohua, Chen, Quan, Yu, Lei, Wang, Peng, Zhang, Qi, Dong, Jiang, Zhang, Wei, Huang, Junxing · 2021 · International Journal of Nanomedicine

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Background: Radiotherapy occupies an essential position as one of the most significant approaches for the clinical treatment of cancer. However, we cannot overcome the shortcoming of X-rays which is the high value of the oxygen enhancement ratio (OER). Radiosensitizers with the ability to enhance the radiosensitivity of tumor cells provide an alternative to changing X-rays to protons and heavy ion radiotherapy. Materials and Methods: We prepared the Au-Pt nanoparticles (Au-Pt NPs) using a one-step method. The characteristics of the Au-Pt NPs were determined using TEM, HAADF-STEM, elemental mapping images, and DLS. The enhanced radiotherapy was demonstrated in vitro using MTT assays, colony formation assays, fluorescence imaging, and flow cytometric analyses of the apoptosis. The biodistribution of the Au-Pt NPs was analyzed using ICP-OES, and thermal images. The enhanced radiotherapy was demonstrated in vitro using immunofluorescence images, tumor volume and weigh, and hematoxylin & eosin (H&E) staining. Results: Polyethylene glycol (PEG) functionalized nanoparticles composed of the metallic elements Au and Pt were designed to increase synergistic radiosensitivity. The mechanism demonstrated that heavy metal NPs possess a high X-ray photon capture cross-section and Compton scattering effect which increased DNA damage. Furthermore, the Au-Pt NPs exhibited enzyme-mimicking activities by catalyzing the decomposition of endogenous H 2 O 2 to O 2 in the solid tumor microenvironment (TME). Conclusion: Our work provides a systematically administered radiosensitizer that can selectively reside in a tumor via the EPR effect and enhances the efficiency of treating cancer with radiotherapy. Keywords: radiosensitizer, nano-enzyme, TME, radiotherapy

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ijn.s287523

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Scheme 1 Schematic illustrations for the fabrication of Au-Pt NPs and synergistic radiotherapy by employing tumor microenvironment.
Scheme 1 Schematic illustrations for the fabrication of Au-Pt NPs and synergistic radiotherapy by employing tumor microenvironment.CC BY-NC · PubMed Central
Figure 1 The schematic procedure and characterization of Au-Pt NPs. (A) TEM image, (B) the high-angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) and elemental mapping images, (C) Hydrodynamic diameters of Au-Pt NPs in 10% FBS and PBS measured by DLS, (D) Zeta potential of Au-Pt NPs, (E) Hydrodynamic diameters of Au-Pt NPs 10% FBS and PBS at different times, (F) Oxygen generation in H2O2 solution (3.2 mM) with different concentrations of Au-Pt NPs at pH 6.75.
Figure 1 The schematic procedure and characterization of Au-Pt NPs. (A) TEM image, (B) the high-angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) and elemental mapping images, (C) Hydrodynamic diameters of Au-Pt NPs in 10% FBS and PBS measured by DLS, (D) Zeta potential of Au-Pt NPs, (E) Hydrodynamic diameters of Au-Pt NPs 10% FBS and PBS at different times, (F) Oxygen generation in H2O2 solution (3.2 mM) with different concentrations of Au-Pt NPs at pH 6.75.CC BY-NC · PubMed Central
Figure 2 Relative cell viability of HUEVC cells and 4T1 cells treated with Au-Pt NPs (A) and irradiation (B) for 24 h. (C) Relative cell viability of 4T1 cells after irradiation for 24 h treated with Au-Pt NPs. (D) Clonogenic cell survival curve was generated for 4T1 cells. (E) Representative immunofluorescence images of phosphorylated H2AX (γH2AX) in 4T1 cells after irradiation for 24 h treated with Au-Pt NPs.
Figure 2 Relative cell viability of HUEVC cells and 4T1 cells treated with Au-Pt NPs (A) and irradiation (B) for 24 h. (C) Relative cell viability of 4T1 cells after irradiation for 24 h treated with Au-Pt NPs. (D) Clonogenic cell survival curve was generated for 4T1 cells. (E) Representative immunofluorescence images of phosphorylated H2AX (γH2AX) in 4T1 cells after irradiation for 24 h treated with Au-Pt NPs.CC BY-NC · PubMed Central
Figure 3 (A) LIVE/DEAD staining of 4T1 cells by staining with FDA (green) and PI (red) after different treatments (scale bar: 200 μm). (B, C) Flow cytometric analysis of the apoptosis of 4T1 cells by staining with Annexin V-FITC and PI after different treatments (*P < 0.01).
Figure 3 (A) LIVE/DEAD staining of 4T1 cells by staining with FDA (green) and PI (red) after different treatments (scale bar: 200 μm). (B, C) Flow cytometric analysis of the apoptosis of 4T1 cells by staining with Annexin V-FITC and PI after different treatments (*P < 0.01).CC BY-NC · PubMed Central
Figure 4 (A) Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES) analysis of Au-Pt NPs after tail intravenous injection for different times. (B) Organ biodistribution according to ICP-OES signal (N = 3 animals) with Au-Pt NPs. Data represent mean ± s.d. (C) The thermal images of 4T1 tumor bearing mice with injection of Au-Pt NPs for different times.
Figure 4 (A) Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES) analysis of Au-Pt NPs after tail intravenous injection for different times. (B) Organ biodistribution according to ICP-OES signal (N = 3 animals) with Au-Pt NPs. Data represent mean ± s.d. (C) The thermal images of 4T1 tumor bearing mice with injection of Au-Pt NPs for different times.CC BY-NC · PubMed Central
Figure 5 (A) Representative immunofluorescence images of tumor slices after hypoxia staining (scale bar: 100 μm). The hypoxia areas were stained by anti-pimonidazole antibody (green, FITC). (B) Relative tumor volume after various treatments indicated. (C) Tumor weight of sacrificed mice at Day 16 (*P< 0.01). (D) Change curves for the body weight of mice. (E) H&E staining of tumor tissues at Day 16 (scale bar: 100 μm).
Figure 5 (A) Representative immunofluorescence images of tumor slices after hypoxia staining (scale bar: 100 μm). The hypoxia areas were stained by anti-pimonidazole antibody (green, FITC). (B) Relative tumor volume after various treatments indicated. (C) Tumor weight of sacrificed mice at Day 16 (*P< 0.01). (D) Change curves for the body weight of mice. (E) H&E staining of tumor tissues at Day 16 (scale bar: 100 μm).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

Metadata

Authors
Yang, S., Han, G., Chen, Q., Yu, L., Wang, P., Zhang, Q., Dong, J., Zhang, W., & Huang, J.
Affiliations
Nantong University (CN)
Corresponding author
Zhang, Wei
Venue
International Journal of Nanomedicine
Published
2021-01
Volume
Volume 16
Pages
239-248
ISSN
  • 1176-9114 (ISSN-L)
  • 1178-2013
OpenAlex
W3119811879
Cited by
81
References
41
Citations by year
2026: 22 · 2025: 18 · 2024: 15 · 2023: 13 · 2022: 11 · 2021: 2
FWCI
6.66
Type
journal article
Language
en
Open access
Locations
  • International Journal of Nanomedicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
Jiangsu Provincial Commission of Health and Family Planning (H2017076)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
Keywords
Au@Pt nanoparticles, radiosensitizers, radiotherapy, oxygen enhancement ratio, nanozymes, hydrogen peroxide decomposition, tumor microenvironment, enhanced permeability and retention effect, Compton scattering, DNA damage, apoptosis, tissue distribution
MeSH terms
Animals, Catalysis, Cell Survival, Female, Gold, Humans, Mice, Inbred BALB C, Neoplasms, Platinum, Radiation-Sensitizing Agents, Tissue Distribution, Cell Line, Tumor, Mice, Metal Nanoparticles, Tumor Microenvironment, Human Umbilical Vein Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.